- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- monomer
- Ligands
- 1 x RET: RETINAL(Covalent)
- 11 x LFA: EICOSANE(Non-covalent)(Non-functional Binders)
LFA.2: 8 residues within 4Å:- Chain A: G.22, L.23, A.52, F.55, T.56
- Ligands: LFA.12, KR.38, KR.40
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:A.52, A:F.55, A:F.55, A:F.55, A:T.56
LFA.3: 2 residues within 4Å:- Chain A: L.110
- Ligands: LFA.6
No protein-ligand interaction detected (PLIP)LFA.4: 4 residues within 4Å:- Chain A: G.198, I.199, V.200, P.201
No protein-ligand interaction detected (PLIP)LFA.5: 1 residues within 4Å:- Ligands: OLA.14
No protein-ligand interaction detected (PLIP)LFA.6: 7 residues within 4Å:- Chain A: L.88, V.113, G.117, G.121
- Ligands: LFA.3, KR.24, KR.35
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.88, A:V.113
LFA.7: 4 residues within 4Å:- Chain A: S.133, F.136, V.137
- Ligands: KR.44
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:F.136
LFA.8: 6 residues within 4Å:- Chain A: L.16, L.20, V.214, S.215, G.219
- Ligands: KR.27
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.16, A:L.20, A:V.214
LFA.9: 4 residues within 4Å:- Chain A: V.180, V.181, S.184, A.185
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:V.180, A:V.181, A:A.185
LFA.10: 4 residues within 4Å:- Chain A: W.11, A.15, L.62
- Ligands: KR.52
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:W.11, A:A.15, A:L.62
LFA.11: 7 residues within 4Å:- Chain A: A.115, I.141, A.145, Y.148
- Ligands: OLA.15, KR.23, KR.54
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:A.115, A:A.145, A:Y.148
LFA.12: 9 residues within 4Å:- Chain A: L.29, A.45, A.48, L.49, A.52
- Ligands: LFA.2, KR.32, KR.38, KR.51
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.29, A:A.45, A:A.52
- 3 x OLA: OLEIC ACID(Non-covalent)
OLA.13: 6 residues within 4Å:- Chain A: L.147, L.150, Y.151, F.154, F.155
- Ligands: HEX.18
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:Y.151, A:F.154, A:F.154, A:F.154, A:F.154, A:F.155, A:F.155
OLA.14: 6 residues within 4Å:- Chain A: G.219, L.222, I.223, R.226
- Ligands: LFA.5, KR.25
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.222, A:I.223
- Water bridges: A:I.223
- Salt bridges: A:R.226
OLA.15: 3 residues within 4Å:- Chain A: A.111, Y.148
- Ligands: LFA.11
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:A.111
- Water bridges: A:T.108
- 3 x HEX: HEXANE(Non-covalent)
HEX.16: 3 residues within 4Å:- Chain A: F.89
- Ligands: KR.46, KR.49
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:F.89
HEX.17: 3 residues within 4Å:- Chain A: W.81, L.124, L.128
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:W.81, A:W.81, A:W.81
HEX.18: 4 residues within 4Å:- Chain A: A.144, Y.148, Y.151
- Ligands: OLA.13
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:Y.151, A:Y.151, A:Y.151
- 1 x SO4: SULFATE ION(Non-functional Binders)
- 35 x KR: KRYPTON(Non-covalent)(Non-functional Binders)
KR.20: 6 residues within 4Å:- Chain A: L.94, L.95, L.98, T.179, W.183, F.220
Ligand excluded by PLIPKR.21: 2 residues within 4Å:- Chain A: A.15, L.16
Ligand excluded by PLIPKR.22: 3 residues within 4Å:- Chain A: L.95, L.96, I.109
Ligand excluded by PLIPKR.23: 3 residues within 4Å:- Chain A: A.115, I.118
- Ligands: LFA.11
Ligand excluded by PLIPKR.24: 4 residues within 4Å:- Chain A: Y.84, L.88, L.124
- Ligands: LFA.6
Ligand excluded by PLIPKR.25: 4 residues within 4Å:- Chain A: V.178, S.215, G.219
- Ligands: OLA.14
Ligand excluded by PLIPKR.26: 3 residues within 4Å:- Chain A: V.181, L.182
- Ligands: KR.53
Ligand excluded by PLIPKR.27: 3 residues within 4Å:- Chain A: V.218, L.222
- Ligands: LFA.8
Ligand excluded by PLIPKR.28: 2 residues within 4Å:- Chain A: L.110, A.111
Ligand excluded by PLIPKR.29: 1 residues within 4Å:- Chain A: L.29
Ligand excluded by PLIPKR.30: 4 residues within 4Å:- Chain A: S.60, Y.65, G.66, W.81
Ligand excluded by PLIPKR.31: 2 residues within 4Å:- Chain A: S.60, Y.65
Ligand excluded by PLIPKR.32: 3 residues within 4Å:- Chain A: A.48, L.49
- Ligands: LFA.12
Ligand excluded by PLIPKR.33: 3 residues within 4Å:- Chain A: T.143, P.187
- Ligands: KR.34
Ligand excluded by PLIPKR.34: 2 residues within 4Å:- Chain A: S.184
- Ligands: KR.33
Ligand excluded by PLIPKR.35: 6 residues within 4Å:- Chain A: L.88, P.92, V.113, D.116, G.117
- Ligands: LFA.6
Ligand excluded by PLIPKR.36: 2 residues within 4Å:- Chain A: L.110, G.114
Ligand excluded by PLIPKR.37: 3 residues within 4Å:- Chain A: Y.27, K.31, L.225
Ligand excluded by PLIPKR.38: 3 residues within 4Å:- Chain A: L.29
- Ligands: LFA.2, LFA.12
Ligand excluded by PLIPKR.39: 3 residues within 4Å:- Chain A: L.182, V.211, S.215
Ligand excluded by PLIPKR.40: 2 residues within 4Å:- Chain A: T.56
- Ligands: LFA.2
Ligand excluded by PLIPKR.41: 2 residues within 4Å:- Chain A: T.56
- Ligands: KR.48
Ligand excluded by PLIPKR.42: 3 residues within 4Å:- Chain A: L.191, A.197, I.199
Ligand excluded by PLIPKR.43: 7 residues within 4Å:- Chain A: T.122, G.123, G.126, W.138, W.139, W.190
- Ligands: RET.1
Ligand excluded by PLIPKR.44: 3 residues within 4Å:- Chain A: F.136, W.139
- Ligands: LFA.7
Ligand excluded by PLIPKR.45: 2 residues within 4Å:- Chain A: L.208, L.212
Ligand excluded by PLIPKR.46: 3 residues within 4Å:- Chain A: P.92, L.96
- Ligands: HEX.16
Ligand excluded by PLIPKR.47: 4 residues within 4Å:- Chain A: M.57, A.85, F.89
- Ligands: KR.48
Ligand excluded by PLIPKR.48: 4 residues within 4Å:- Chain A: T.56
- Ligands: KR.41, KR.47, KR.49
Ligand excluded by PLIPKR.49: 2 residues within 4Å:- Ligands: HEX.16, KR.48
Ligand excluded by PLIPKR.50: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPKR.51: 3 residues within 4Å:- Chain A: I.46, L.49
- Ligands: LFA.12
Ligand excluded by PLIPKR.52: 3 residues within 4Å:- Chain A: W.11, A.15
- Ligands: LFA.10
Ligand excluded by PLIPKR.53: 4 residues within 4Å:- Chain A: N.177, V.178, V.181
- Ligands: KR.26
Ligand excluded by PLIPKR.54: 2 residues within 4Å:- Chain A: I.141
- Ligands: LFA.11
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Melnikov, I. et al., High-pressure crystallography shows noble gas intervention into protein-lipid interaction and suggests a model for anaesthetic action. Commun Biol (2022)
- Release Date
- 2022-04-27
- Peptides
- Bacteriorhodopsin: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- monomer
- Ligands
- 1 x RET: RETINAL(Covalent)
- 11 x LFA: EICOSANE(Non-covalent)(Non-functional Binders)
- 3 x OLA: OLEIC ACID(Non-covalent)
- 3 x HEX: HEXANE(Non-covalent)
- 1 x SO4: SULFATE ION(Non-functional Binders)
- 35 x KR: KRYPTON(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Melnikov, I. et al., High-pressure crystallography shows noble gas intervention into protein-lipid interaction and suggests a model for anaesthetic action. Commun Biol (2022)
- Release Date
- 2022-04-27
- Peptides
- Bacteriorhodopsin: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.